Erlotinib: A Targeted Anticancer Drug

Publisher: Bentham Science Publishers

E-ISSN: 1875-6301|13|1|3-16

ISSN: 1573-3947

Source: Current Cancer Therapy Reviews, Vol.13, Iss.1, 2017-08, pp. : 3-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract